| TVARDI THERAPEUTICS O.N. |
| USA |
| Gesundheit |
| US1407553072 / A414VY |
| 69C (Frankfurt) / TVRD (NASDAQ) |
| FRA:69C, ETR:69C, 69C:GR, NASDAQ:TVRD |
| - |
| https://tvarditherapeutic.. |
|
Cara Therapeutics Inc. is a biopharmaceutical company developing innovative treatments targeting the peripheral nervous system and immune cells. The company's lead product, KORSUVA, represents a significant advancement in addressing chronic itch and ..
>Volltext.. |
| 41.03 Mio. EUR |
| 19.59 Mio. EUR |
| - |
| -25.65 Mio. EUR |
| -13.5 Mio. EUR |
| -1.39 EUR |
| 0.15 Mio. EUR |
| 17.36 Mio. EUR |
| -21.58 Mio. EUR |
| 2.22 |
| -100% |
| 67.93% |
| - |
| - |
| - |
| - |
| TVARDI |
| 10.07.26 |
|